|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.65 CNY | 0.00% |
|
+3.52% | +0.17% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.49 | +38.74% | 8 | ||||||
| 61.48 | +90.2% | 16 | ||||||
| 4.639 | +54.43% | 15 | ||||||
| 2,979 | +22.92% | 10 | ||||||
| 33.22 | +65.17% | 12 | ||||||
| 338.5 | +50.44% | 8 | ||||||
| 125.87 | +36.97% | 9 | ||||||
| 47 | +14.75% | 6 | ||||||
| - | - | 1,415 | +216.05% | 1 | ||||
| 37.19 | +14.07% | 8 | ||||||
| 79.67 | +29.33% | 9 | ||||||
| 1,168.71 | +41.47% | 7 | ||||||
| 56.82 | +33.45% | 8 | ||||||
| 14.86 | +46.86% | 5 | ||||||
| - | 90 | +20.4% | 2 | |||||
| - | 5,100 | +35.64% | 2 | |||||
| Average | 723.53 | +50.68% | 8 | ||||||
| Weighted average by Cap. | 538.83 | +61.66% | 11 |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
